Daxor Corporation - Closed End Fund (NQ:DXR)

10.14 -0.71 (-6.54%)

Streaming Delayed Price Updated: 2:11 PM EDT, May 6, 2026 Add to My Watchlist

Price and Volume

Volume	22,399
Open	11.24
Bid (Size)	9.200 (100)
Ask (Size)	10.05 (2,000)
Prev. Close	10.85
Today's Range	10.00 - 11.24
52wk Range	7.100 - 14.76
Shares Outstanding	4,196,182
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026

March 10, 2026

Via ACCESS Newswire

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Performance

YTD	-29.4%	-29.4%
1 Month	+12.4%	+12.4%
3 Month	-19.5%	-19.5%
6 Month	-20.5%	-20.5%
1 Year	+33.9%	+33.9%

More News

Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

May 22, 2023

Via Benzinga

Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option

November 17, 2022

From Daxor Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 15, 2022

Via Benzinga

Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected ↗

November 15, 2022

Via Benzinga

Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering

November 15, 2022

From Daxor Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 15, 2022

Via Benzinga

Daxor Corporation Announces Launch of Proposed Underwritten Public Offering

November 14, 2022

From Daxor Corporation

Via GlobeNewswire

Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes and Reduce Costs

November 10, 2022

From Daxor Corporation

Via GlobeNewswire

Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure

November 03, 2022

From Daxor Corporation

Via GlobeNewswire

Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022

October 31, 2022

From Daxor Corporation

Via GlobeNewswire

Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

October 05, 2022

From Daxor Corporation

Via GlobeNewswire

DAXOR CORPORATION TO EXHIBIT AND PRESENT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’22 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)

October 04, 2022

From Daxor Corporation

Via GlobeNewswire

Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting

October 04, 2022

From Daxor Corporation

Via GlobeNewswire

New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%

October 03, 2022

From Daxor Corporation

Via GlobeNewswire

New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care

October 03, 2022

From Daxor Corporation

Via GlobeNewswire

New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures

October 03, 2022

From Daxor Corporation

Via GlobeNewswire

Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.

July 27, 2022

From Daxor Corporation

Via GlobeNewswire

32 Stocks Moving in Friday's Pre-Market Session ↗

July 23, 2021

Via Benzinga

64 Biggest Movers From Friday ↗

June 07, 2021

Via Benzinga

35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

May 27, 2021

From MicroCap Rodeo

Via AccessWire

Stocks That Hit 52-Week Lows On Thursday ↗

May 13, 2021

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 16, 2021

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 13, 2021

Via Benzinga

Frequently Asked Questions

Is Daxor Corporation - Closed End Fund publicly traded?

Yes, Daxor Corporation - Closed End Fund is publicly traded.

What exchange does Daxor Corporation - Closed End Fund trade on?

Daxor Corporation - Closed End Fund trades on the Nasdaq Stock Market

What is the ticker symbol for Daxor Corporation - Closed End Fund?

The ticker symbol for Daxor Corporation - Closed End Fund is DXR on the Nasdaq Stock Market

What is the current price of Daxor Corporation - Closed End Fund?

The current price of Daxor Corporation - Closed End Fund is 10.14

When was Daxor Corporation - Closed End Fund last traded?

The last trade of Daxor Corporation - Closed End Fund was at 05/06/26 02:11 PM ET

What is the market capitalization of Daxor Corporation - Closed End Fund?

The market capitalization of Daxor Corporation - Closed End Fund is 42.55M

How many shares of Daxor Corporation - Closed End Fund are outstanding?

Daxor Corporation - Closed End Fund has 43M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.